In summary, our study provided insights into the mechanisms employed by GASC1 to propagate malignant phenotypes in HCC and provides a rationale for clinical trials to investigate GASC1 inhibition combined with chemotherapy as a novel therapeutic strategy in HCC with high levels of GASC1 gene expression. The gene discussed is KDM4C; the disease is hepatocellular carcinoma.